RB1 and adenocarcinoma: To determine if MYCN expression synergizes with Rb1 loss to drive a molecular program associated with NEPC, we performed bulk RNA-seq on histologically distinct tumor foci ranging from adenocarcinoma to NEPC (Fig. 2a).